Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
245.6 EUR | -0.14% |
|
-.--% | -.--% |
25/06 | Halozyme Therapeutics Says Roche's OCREVUS SC With ENHANZE Gets European Commission Approval | MT |
25/06 | Roche: approval of Ocrevus SC in Europe | CF |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ROCHE HOLDING AG | Other Pharmaceuticals | -0.14% | -.--% | -.--% | -.--% | -1.33% | 23TCr | - | - | - |
- Stock Market
- Equities
- ROG Stock
- RHO5 Stock
- Charts Roche Holding AG
- Relative Strength Chart